Effectiveness of Midwife Phone Support With the to Reduce the Early Abandonment of Breastfeeding (STAM)

June 3, 2019 updated by: Jordi Gol i Gurina Foundation

Objective: To evaluate the effectiveness of telephone support of the reference midwife, in relation to the abandonment of breastfeeding of primiparous mothers and to identify, both the risk factors and the protective factors for the early abandonment of breastfeeding.

Material and Method Randomized parallel controlled clinical trial.

Study Overview

Status

Completed

Conditions

Detailed Description

Sample: 220 primiparous mothers with access, during the 8 weeks postpartum, to a mobile phone to contact the midwife randomization of 110 mothers to the experimental group and 110 to the control group. The mothers of the experimental group will be offered the mobile phone number to contact their midwife after delivery. The mothers of the control group will receive the usual attention of the portfolio of services that includes the spontaneous visit in the center, the telephone call in the center, the home visit and the health education groups.

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Primiparians who carry out the follow-up of pregnancy for the midwife
  • The pregnant woman is of low risk
  • Possibility of the mother to make calls to the mobile phone.
  • The pregnant woman wishes to participate in the study.

Exclusion Criteria

  • Maternal or fetal pathology that can condition maternal breastfeeding.
  • idiomatic barrier.
  • Prematurity.
  • Baby with weight <2,500 gr. at birth
  • Home delivery during the puerperium

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention group
Mothers received a phone support service with their midwife during the 8 weeks after childbirth.
Mothers can call the midwife's telephone every working day from 8 a.m. to 8 p.m.
NO_INTERVENTION: Control group
Mothers received standard postpartum care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of participants who breast-feed at 3 months of intervention
Time Frame: 3 months
Women who still breastfeed 3 months after the intervention with respect to the control arm
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2012

Primary Completion (ACTUAL)

December 31, 2014

Study Completion (ACTUAL)

December 31, 2017

Study Registration Dates

First Submitted

April 29, 2019

First Submitted That Met QC Criteria

June 3, 2019

First Posted (ACTUAL)

June 4, 2019

Study Record Updates

Last Update Posted (ACTUAL)

June 4, 2019

Last Update Submitted That Met QC Criteria

June 3, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • P10/53-STAM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breastfeeding

Clinical Trials on Phone care support by midwife

Subscribe